Addex Therapeutics Ltd.
Pharmaceutical company · Geneva, Switzerland · Nasdaq: ADXN
Addex Therapeutics Ltd. is a pharmaceutical company headquartered in Geneva, Switzerland. Its shares trade on Nasdaq under the ticker ADXN. It has reported private securities offerings to the US SEC, most recently $3.7 million sold in a notice filed in 2023.
Addex Therapeutics at a glance
What does Addex Therapeutics do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $3.7 million sold (2023).
Frequently asked questions about Addex Therapeutics
Where is Addex Therapeutics headquartered?
Addex Therapeutics Ltd. is headquartered in Geneva, Switzerland.
What does Addex Therapeutics do?
Addex Therapeutics Ltd. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Addex Therapeutics a public company?
Yes. Addex Therapeutics Ltd. trades on Nasdaq under the ticker ADXN.
Similar companies
- MindMaze Therapeutics Holding SAGeneva, Switzerland
- Novartis AgBasel, Basel-City, Switzerland
- BeOne Medicines Ltd.Basel, Basel-City, Switzerland
- NewcelX Ltd.Zürich, Zurich, Switzerland
- MoonLake ImmunotherapeuticsZug, Switzerland
- Oculis Holding AGZug, Switzerland
- ADC Therapeutics SAEpalinges, Vaud, Switzerland
- AC Immune SALausanne, Vaud, Switzerland
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences